Table 3.
Characteristics of the Prophylactic Hemostasis and Nonhemostasis Groups during Second-Look Endoscopy
| Hemostasis (22 lesions) | Nonhemostasis (172 lesions) | p-value | |
|---|---|---|---|
| Age | 55.5±10.3 | 59.2±8.6 | 0.062 |
| Male sex | 19 (86.4) | 129 (75.0) | 0.297 |
| Comorbidities | |||
| Hypertension (present) | 8 (36.4) | 58 (33.7) | 0.814 |
| Diabetes mellitus (present) | 6 (27.3) | 27 (15.7) | 0.223 |
| Heart disease (present) | 0 | 1 (0.6) | 1.000 |
| Anticoagulants/platelets (used) | 2 (9.1) | 17 (9.9) | 1.000 |
| Histologic type | |||
| Adenoma/adenocarcinoma | 5/17 | 63/109 | 0.241 |
| Location | |||
| Upper/mid/lower third | 1/4/17 | 8/56/108 | 0.379 |
| AW/PW/LC/GC | 2/1/16/3 | 24/28/77/43 | 0.094 |
| Macroscopic type | |||
| Elevated/flat or depressed | 14/8 | 123/49 | 0.462 |
| Size of the tumor, mm | 13.2±8.5 | 14.3±9.4 | 0.629 |
| Size of the resected specimen, mm | 41.5±10.0 | 42.8±11.8 | 0.613 |
| Resection style, en bloc/piecemeal | 22/0 | 169/3 | 1.000 |
| Procedure time, min | 59.5±30.9 | 57.4±32.8 | 0.772 |
| Anti-ulcer medication after ESD, PPIs/H2RAs | 10/12 | 82/90 | 1.000 |
Data are presented as mean±SD or number (%).
AW, anterior wall; PW, posterior wall; LC, lesser curvature; GC, great curvature; ESD, endoscopic submucosal dissection; PPIs, proton pump inhibitors; H2RAs, histamine-2 receptor antagonists.